These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 9718628)
21. Gender differences in cerebral glucose metabolism: a PET study. Kawachi T; Ishii K; Sakamoto S; Matsui M; Mori T; Sasaki M J Neurol Sci; 2002 Jul; 199(1-2):79-83. PubMed ID: 12084447 [TBL] [Abstract][Full Text] [Related]
22. Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors. Volkow ND; Wang GJ; Fowler JS; Logan J; Angrist B; Hitzemann R; Lieberman J; Pappas N Am J Psychiatry; 1997 Jan; 154(1):50-5. PubMed ID: 8988958 [TBL] [Abstract][Full Text] [Related]
23. Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients. Bartlett EJ; Brodie JD; Simkowitz P; Schlösser R; Dewey SL; Lindenmayer JP; Rusinek H; Wolkin A; Cancro R; Schiffer W Am J Psychiatry; 1998 Mar; 155(3):337-43. PubMed ID: 9501742 [TBL] [Abstract][Full Text] [Related]
24. Apomorphine effects on brain metabolism in neuroleptic-naive schizophrenic patients. Cleghorn JM; Szechtman H; Garnett ES; Nahmias C; Brown GM; Kaplan RD; Szechtman B; Franco S Psychiatry Res; 1991 Oct; 40(2):135-53. PubMed ID: 1763143 [TBL] [Abstract][Full Text] [Related]
25. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients. Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302 [TBL] [Abstract][Full Text] [Related]
26. Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia. Hazlett EA; Buchsbaum MS; Kemether E; Bloom R; Platholi J; Brickman AM; Shihabuddin L; Tang C; Byne W Am J Psychiatry; 2004 Feb; 161(2):305-14. PubMed ID: 14754780 [TBL] [Abstract][Full Text] [Related]
27. Chemical and physiologic brain imaging in schizophrenia. McClure RJ; Keshavan MS; Pettegrew JW Psychiatr Clin North Am; 1998 Mar; 21(1):93-122. PubMed ID: 9551493 [TBL] [Abstract][Full Text] [Related]
29. The current status of PET scanning with respect to schizophrenia. Sedvall G Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021 [TBL] [Abstract][Full Text] [Related]
30. 6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography. Elkashef AM; Doudet D; Bryant T; Cohen RM; Li SH; Wyatt RJ Psychiatry Res; 2000 Nov; 100(1):1-11. PubMed ID: 11090720 [TBL] [Abstract][Full Text] [Related]
31. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Buchsbaum MS; Tang CY; Peled S; Gudbjartsson H; Lu D; Hazlett EA; Downhill J; Haznedar M; Fallon JH; Atlas SW Neuroreport; 1998 Feb; 9(3):425-30. PubMed ID: 9512384 [TBL] [Abstract][Full Text] [Related]
32. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics. Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197 [TBL] [Abstract][Full Text] [Related]
33. Thalamic and prefrontal FDG uptake in never medicated patients with schizophrenia. Lehrer DS; Christian BT; Mantil J; Murray AC; Buchsbaum BR; Oakes TR; Byne W; Kemether EM; Buchsbaum MS Am J Psychiatry; 2005 May; 162(5):931-8. PubMed ID: 15863795 [TBL] [Abstract][Full Text] [Related]
34. Metabolic subtypes in patients with schizophrenia. Clark CM; Kopala L; James G; Hurwitz T; Li D Biol Psychiatry; 1993 Jan; 33(2):86-92. PubMed ID: 8439608 [TBL] [Abstract][Full Text] [Related]
35. [Effects of anti-psychotic agents on brain glucose metabolism and regional cerebral circulation in patients with schizophrenia-- study by functional brain imaging of SPECT and PET]. Jibiki I Seishin Shinkeigaku Zasshi; 2002; 104(2):144-51. PubMed ID: 11985069 [No Abstract] [Full Text] [Related]
36. Sight and insight: regional cerebral metabolic activity in schizophrenia visualised by positron emission tomography, and competing neurodevelopmental perspectives. Waddington JL Br J Psychiatry; 1990 May; 156():615-9. PubMed ID: 2095940 [No Abstract] [Full Text] [Related]
37. Temporal lobe metabolic differences in medication-free outpatients with schizophrenia via the PET-600. Nordahl TE; Kusubov N; Carter C; Salamat S; Cummings AM; O'Shora-Celaya L; Eberling J; Robertson L; Huesman RH; Jagust W; Budinger TF Neuropsychopharmacology; 1996 Dec; 15(6):541-54. PubMed ID: 8946428 [TBL] [Abstract][Full Text] [Related]
38. Metabolic disconnection between the mediodorsal nucleus of the thalamus and cortical Brodmann's areas of the left hemisphere in schizophrenia. Mitelman SA; Byne W; Kemether EM; Hazlett EA; Buchsbaum MS Am J Psychiatry; 2005 Sep; 162(9):1733-5. PubMed ID: 16135634 [TBL] [Abstract][Full Text] [Related]
40. No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457. Talvik M; Nordström AL; Nyberg S; Olsson H; Halldin C; Farde L Am J Psychiatry; 2001 Jun; 158(6):926-30. PubMed ID: 11384901 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]